JY
CELZ icon

Jeff Yass’s Creative Medical Technology CELZ Stock Holding History

Jeff Yass’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,469
Closed -$21.6K – 13469
2026
Q1 		$21.6K Buy
+10,469
New +$20.5K ﹤0.01% 12849
2023
Q2 		– Sell
-2,137
Closed -$10.7K – 12144
2023
Q1 		$10.7K Buy
+2,137
New +$12.1K ﹤0.01% 12191
2022
Q1 		– Sell
-2,270
Closed -$50K – 13045
2021
Q4 		$50K Buy
+2,270
New +$47.6K ﹤0.01% 12537

Other funds holding CELZ

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's CELZ Position: Q2 2026 in Review

Jeff Yass sold out of Creative Medical Technology (CELZ) in Q2 2026, closing a stake of 10,469 shares — an estimated $21.6K sold.

Jeff Yass first reported a position in CELZ in Q4 2021 and held it in 3 quarters. The position peaked at $50K in Q4 2021. 15 funds tracked by Wall St. Rank hold CELZ as of Q2 2026.

  • Jeff Yass reported no remaining Creative Medical Technology position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 10,469 Creative Medical Technology shares in Q2 2026, an estimated $21.6K.
  • Jeff Yass first reported a position in Creative Medical Technology in Q4 2021 and held it in 3 quarters.
  • Jeff Yass's Creative Medical Technology position peaked at $50K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.